<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04039659</url>
  </required_header>
  <id_info>
    <org_study_id>2019-1-6-HCUVA</org_study_id>
    <nct_id>NCT04039659</nct_id>
  </id_info>
  <brief_title>POstoperative Negative-pressure Incision Therapy Following LIver TRANSplant:a Randomized Controlled Trial</brief_title>
  <acronym>PONILITRANS</acronym>
  <official_title>POstoperative Negative-pressure Incision Therapy Following LIver TRANSplant (PONILITRANS Study): a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Virgen de la Arrixaca</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario Virgen de la Arrixaca</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to evaluate whether the prophylactic use of a negativa pressure therapy device
      (PICOⓇ) on the closed wound of the liver transplant, reduces the postoperative complications
      of surgical wounds, compared to the use of dressings conventional postoperative
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative complications of surgical wounds are frequent after surgical procedures, even
      more in the context of liver transplantation given the necessary immunosuppression, high
      surgical time, high hospital stay and intensive care, politransfusions, etc. Negative
      pressure therapy is well established for the treatment of open wounds, its use having been
      recently indicated on closed surgical wounds. The evidence to justify this intervention is
      still limited.

      The objective of our clinical trial is to evaluate whether the prophylactic use of a negative
      pressure therapy device (PICOⓇ) on the closed wound of the liver transplant, reduces the
      postoperative complications of surgical wounds, compared to the use of dressings conventional
      postoperative After signing the informed consent of those patients who meet the inclusion
      criteria, they will be randomized into two groups to install the PICOⓇ device or conventional
      dressings on the wound. After 7 days, the PICOⓇ device will be removed and both preoperative
      and postoperative variables will be studied in terms of incidence of surgical site events,
      stay, etc.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>After signing the informed consent of those patients who meet the inclusion criteria, they will be randomized into two groups to install the PICOⓇ device or conventional dressings over the wound. After 7 days, the PICOⓇ device will be removed and both preoperative and postoperative variables will be studied.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence rate of surgical site</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Any complication of surgical site will be registered</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life of transplantation patient</measure>
    <time_frame>6 months</time_frame>
    <description>We will use Cardiff Wound Impact Schedule to evaluate the possible improvement in the quality of life of transplantation patients derived from the decrease in the requirement of health resources.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nosocomial infection rate</measure>
    <time_frame>30 days after surgery (3rd, 7th, 15th and 30th post trasplant)</time_frame>
    <description>To verify the change in rates of nosocomial infections in the context of liver transplantation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Liver Transplant; Complications</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will be cured with dressings wound everyday or before if there are complications in surgical incisions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PICO group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will carry the device for 7 days uninterrupted until its withdrawal.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Negative-pressure wound therapy (PICO)</intervention_name>
    <description>After the selection of patients and the signing of the consent, patients will be randomized and the device will be placed to those who belong to the PICO group in the operating room.</description>
    <arm_group_label>PICO group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of both sexes aged between 18 and 70 years included in the waiting list for
             liver transplantation by the committee of the Virgen de la Arrixaca University
             Hospital.

        Exclusion Criteria:

          -  To have been rejected for liver transplantation by said committee
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ana Delegido García</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínico Universitario Virgen de la Arrixaca</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Víctor López López</last_name>
    <phone>+34 637519516</phone>
    <email>victorrelopez@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ana Delegido García</last_name>
    <phone>+ 34 686556188</phone>
    <email>ana.delegido.garcia@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Clínico Universitario Virgen de la Arrixaca</name>
      <address>
        <city>El Palmar</city>
        <state>Murcia</state>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Víctor López López</last_name>
      <phone>+34 637519516</phone>
      <email>victorrelopez@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ana Delegido García</last_name>
      <phone>+34 686556188</phone>
      <email>ana.delegido.garcia@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG, Banerjee SN, Edwards JR, Tolson JS, Henderson TS, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med. 1991 Sep 16;91(3B):152S-157S.</citation>
    <PMID>1656747</PMID>
  </reference>
  <reference>
    <citation>Haley RW, Culver DH, Morgan WM, White JW, Emori TG, Hooton TM. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol. 1985 Feb;121(2):206-15.</citation>
    <PMID>4014116</PMID>
  </reference>
  <reference>
    <citation>Webster J, Scuffham P, Sherriff KL, Stankiewicz M, Chaboyer WP. Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD009261. doi: 10.1002/14651858.CD009261.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(10):CD009261.</citation>
    <PMID>22513974</PMID>
  </reference>
  <reference>
    <citation>Kilpadi DV, Cunningham MR. Evaluation of closed incision management with negative pressure wound therapy (CIM): hematoma/seroma and involvement of the lymphatic system. Wound Repair Regen. 2011 Sep-Oct;19(5):588-96. doi: 10.1111/j.1524-475X.2011.00714.x.</citation>
    <PMID>22092797</PMID>
  </reference>
  <reference>
    <citation>Malmsjö M, Huddleston E, Martin R. Biological effects of a disposable, canisterless negative pressure wound therapy system. Eplasty. 2014 Apr 2;14:e15. eCollection 2014.</citation>
    <PMID>24741386</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 10, 2019</study_first_submitted>
  <study_first_submitted_qc>July 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2019</study_first_posted>
  <last_update_submitted>July 29, 2019</last_update_submitted>
  <last_update_submitted_qc>July 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Virgen de la Arrixaca</investigator_affiliation>
    <investigator_full_name>Ana Delegido Garcia</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>wound complications</keyword>
  <keyword>negative-pressure wound therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All documentation related to the study will remain stored in the Investigator's Archive, in the participating center, in the custody of the Principal Investigator until the end of it. Once the study is finished, the documentation will be indexed and will go to the general file of the center.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Data will be available when the results are published.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

